Vanessa Cooper

Summary

Affiliation: University of London
Country: UK

Publications

  1. ncbi Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz
    Vanessa Cooper
    Department of Practice and Policy, Centre for Behavioural Medicine, The School of Pharmacy, University of London, London, UK
    AIDS Care 23:705-13. 2011
  2. ncbi The impact of once-nightly versus twice-daily dosing and baseline beliefs about HAART on adherence to efavirenz-based HAART over 48 weeks: the NOCTE study
    Vanessa Cooper
    Department of Practice and Policy, Center for Behavioural Medicine, The School of Pharmacy, University of London, Mezzanine Floor, BMA House, Tavistock Square, London WC1H 9JP, United Kingdom
    J Acquir Immune Defic Syndr 53:369-77. 2010
  3. ncbi Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework
    Robert Horne
    Centre for Behavioural Medicine, Department of Policy and Practice, The School of Pharmacy, University of London, and Brighton University Hospital, National Health Service Trust, The Lawson Unit, United Kingdom
    J Acquir Immune Defic Syndr 45:334-41. 2007
  4. ncbi Initiation of therapy with a subcutaneously administered antiretroviral in treatment-experienced HIV-infected patients: understanding physician and patient perspectives
    Rob Horne
    Department of Practice and Policy, Centre for Behavioural Medicine, School of Pharmacy, University of London, UK
    AIDS Care 20:1029-38. 2008
  5. ncbi The perceived sensitivity to medicines (PSM) scale: an evaluation of validity and reliability
    Rob Horne
    The UCL School of Pharmacy, University of London, UK
    Br J Health Psychol 18:18-30. 2013

Detail Information

Publications5

  1. ncbi Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz
    Vanessa Cooper
    Department of Practice and Policy, Centre for Behavioural Medicine, The School of Pharmacy, University of London, London, UK
    AIDS Care 23:705-13. 2011
    ..Switching from CBV to TVD may improve patient reported outcomes including slightly better adherence, a greater reduction in concerns about adverse effects and less treatment intrusiveness...
  2. ncbi The impact of once-nightly versus twice-daily dosing and baseline beliefs about HAART on adherence to efavirenz-based HAART over 48 weeks: the NOCTE study
    Vanessa Cooper
    Department of Practice and Policy, Center for Behavioural Medicine, The School of Pharmacy, University of London, Mezzanine Floor, BMA House, Tavistock Square, London WC1H 9JP, United Kingdom
    J Acquir Immune Defic Syndr 53:369-77. 2010
    ..To determine the impact of once-nightly versus twice-daily dosing and beliefs about highly active antiretroviral therapy (HAART) on adherence to efavirenz-based HAART in antiretroviral-naive patients...
  3. ncbi Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework
    Robert Horne
    Centre for Behavioural Medicine, Department of Policy and Practice, The School of Pharmacy, University of London, and Brighton University Hospital, National Health Service Trust, The Lawson Unit, United Kingdom
    J Acquir Immune Defic Syndr 45:334-41. 2007
    ..To test the utility of the necessity-concerns framework in predicting highly active antiretroviral therapy (HAART) uptake and adherence...
  4. ncbi Initiation of therapy with a subcutaneously administered antiretroviral in treatment-experienced HIV-infected patients: understanding physician and patient perspectives
    Rob Horne
    Department of Practice and Policy, Centre for Behavioural Medicine, School of Pharmacy, University of London, UK
    AIDS Care 20:1029-38. 2008
    ..Our findings emphasize the need for patients to discuss their treatment goals with their physicians so that they can work together to find the regimen that is most likely to achieve these goals...
  5. ncbi The perceived sensitivity to medicines (PSM) scale: an evaluation of validity and reliability
    Rob Horne
    The UCL School of Pharmacy, University of London, UK
    Br J Health Psychol 18:18-30. 2013
    ..Design.  The internal consistency, test-retest reliability, criterion-related, and predictive validity of the PSM Scale were evaluated using data collected as part of four previously published studies and one unpublished data set...